ALNY
Alnylam Pharmaceuticals Inc
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||||||
| Capital Expenditures | 58.7M | 34.3M | 62.2M | 72.1M | 76.4M | 70.4M | 140.2M | 126.9M | 104.2M | 64.6M | 4.0M | 8.3M | 1.3M | 4.7M | 4.9M | 10.8M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||||||
| Free Cash Flow | 465.4M | -42.6M | 41.9M | -613.3M | -718.1M | -685.3M | -418.6M | -689.5M | -487.0M | -372.3M | -72.7M | -124.0M | -88.4M | -89.1M | -77.1M | 54.7M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |